| European Case Law Identifier: | ECLI:EP:BA:2003:T009199.20030124 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 24 January 2003 | ||||||||
| Case number: | T 0091/99 | ||||||||
| Application number: | 85904186.5 | ||||||||
| IPC class: | A61K 9/60 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Encapsulation of antineoplastic agents in liposomes | ||||||||
| Applicant name: | THE LIPOSOME COMPANY, INC. | ||||||||
| Opponent name: | NeXstar Pharmaceuticals Inc. Alza Corporation |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Inventive step - no: obvious alternative Apportionment of costs - no |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t990091eu1.html
Date retrieved: 17 May 2021
3 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: III Amendments
XCLR III R 2.2.2 Request for scheduling or postponement of oral proceedings; withdrawal of request for oral proceedings